Stay updated on Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    A new revision entry (v3.3.3) was added to the history. The HHS Vulnerability Disclosure link and the previous revision (v3.3.2) were removed from the footer; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T07:35:04.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Added a new history entry on 2025-12-10 showing updates to Study Status and Contacts/Locations. The 2025-08-07 entry was removed from the history.
    Difference
    0.2%
    Check dated 2025-12-16T02:20:18.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed in the Record History. This reflects a backend version update rather than substantive content changes.
    Difference
    0.0%
    Check dated 2025-12-01T16:32:57.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page history shows a new revision entry (v3.3.1) and removal of an older revision (v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-24T11:15:30.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. The study record history remains visible.
    Difference
    0.2%
    Check dated 2025-11-17T06:11:28.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The screenshot shows a long version history with repeated updates to Study Status and Recruitment Status. Updates to Contacts/Locations and other study details accompany these changes.
    Difference
    0.1%
    Check dated 2025-11-03T00:49:03.000Z thumbnail image

Stay in the know with updates to Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.